By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Marinus Pharmaceuticals 

21 Business Park Drive

Branford  Connecticut  06405  U.S.A.
Phone: 203-315-0566 Fax: 203-315-0565



Start Up

Company News
Marinus Pharmaceuticals (MRNS) To Present At The 21st Annual Biocentury Newsmakers Conference On Friday, September 26, 2014 9/25/2014 7:57:04 AM
Marinus Pharmaceuticals (MRNS) Announces Exercise Of Over-Allotment Option In Public Offering Of Common Stock 9/2/2014 8:11:33 AM
Marinus Pharmaceuticals (MRNS) To Ring The Opening Bell Of The NASDAQ Stock Market 8/25/2014 7:44:39 AM
Marinus Pharmaceuticals (MRNS) Enters Into Use Agreement With CyDex Pharmaceuticals For Use Of Captisol® For Ganaxolone IV 8/12/2014 7:38:07 AM
Epilepsy Biotech Marinus Pharmaceuticals (MRNS) Prices IPO At $10/Share 7/31/2014 7:35:03 AM
Marinus Pharmaceuticals Bolsters Its Board Of Directors And Executive Management 1/9/2014 9:45:34 AM
RusnanoMedInvest and Domain Associates Invest $21 Million in Neurology Company Marinus Pharmaceuticals 1/7/2013 10:28:28 AM
Marinus Pharmaceuticals Experimental Epilepsy Treatment Shows Promise in Open-Label Extension Study 12/21/2011 7:39:41 AM
Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder 4/21/2011 6:59:08 AM
Marinus Pharmaceuticals Announces U.S. Department of Defense Grant to Study Ganaxolone in Fragile-X Syndrome 4/13/2011 11:20:54 AM